LANTHEUS HOLDINGS, INC., as Issuer, LANTHEUS MEDICAL IMAGING, INC., as Guarantor AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 8, 2022 2.625% Convertible Senior Notes due 2027Indenture • December 8th, 2022 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
INDENTURE dated as of December 8, 2022 among LANTHEUS HOLDINGS, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), LANTHEUS MEDICAL IMAGING, INC., a Delaware corporation and a wholly owned subsidiary of the Company, as guarantor (the “Guarantor,” as more fully set forth in Section 1.01) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
